Efficacy and Safety of Adjunctive Oral Ziprasidone for Acute Treatment of Depression in Patients With Bipolar I Disorder-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and Safety of Adjunctive Oral Ziprasidone for Acute Treatment of Depression in Patients With Bipolar I Disorder

Published:2011-05-03 Issue:10 Volume:72 Page:1413-1422
ISSN:0160-6689
Container-title:The Journal of Clinical Psychiatry
language:
Short-container-title:J. Clin. Psychiatry

Author:

Sachs Gary S.,Ice Kathleen S.,Chappell Phillip B.,Schwartz Jeffrey H.,Gurtovaya Oksana,Vanderburg Douglas G.,Kasuba Bryce

Publisher

Physicians Postgraduate Press, Inc

Subject

Psychiatry and Mental health

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Adding Lurasidone to Ongoing Therapy With Lithium or Valproate for the Treatment of an Acute Bipolar Depressive Episode;Journal of Clinical Psychopharmacology;2024-04-19

2. Medications for Bipolar Disorder;Tasman’s Psychiatry;2024

3. Medications for Bipolar Disorder;Tasman’s Psychiatry;2023

4. Treatment-Resistant Bipolar Depression: Therapeutic Trends, Challenges and Future Directions;Neuropsychiatric Disease and Treatment;2022-12

5. Efficacy and safety of adjunctive therapy to lamotrigine, lithium, or valproate monotherapy in bipolar depression: a systematic review and meta-analysis of randomized controlled trials;International Journal of Bipolar Disorders;2022-10-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP